+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Typhoid Drug"

Typhoid Fever - Pipeline Insight, 2024 - Product Thumbnail Image

Typhoid Fever - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Typhoid Fever - Epidemiology Forecast to 2032 - Product Thumbnail Image

Typhoid Fever - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Typhoid Fever - Pipeline Review, H2 2020 - Product Thumbnail Image

Typhoid Fever - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 53 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Typhoid Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Typhoid drugs are specifically used to treat typhoid fever, a bacterial infection caused by the Salmonella typhi bacteria. Treatment typically involves antibiotics, such as ampicillin, chloramphenicol, and ciprofloxacin. Vaccines are also available to prevent typhoid fever. The Typhoid Drug market is highly competitive, with a number of companies offering products. These include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Other companies, such as Bharat Biotech, have recently entered the market with new vaccines. Show Less Read more